Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Church

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Archives of Biochemistry and Biophysics|April 1, 1988
In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitorsC W Pratt, F C Church, S V Pizzo
Journal of Protein Chemistry|November 20, 1997
Assessment of the interaction between urokinase and reactive site mutants of protein C inhibitorT P Jackson, S T Cooper, F C Church
Archives of Biochemistry and Biophysics|April 1, 1986
Structure-function relationships in heparin cofactor II: chemical modification of arginine and tryptophan and demonstration of a two-domain structureF C Church, G B Villanueva, M J Griffith
Archives of Biochemistry and Biophysics|July 2, 1998
Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitorL L Neese, C A Wolfe, F C Church
The Journal of Biological Chemistry|May 30, 1997
Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibitionA V Ciaccia, D M Monroe, F C Church
Blood|January 15, 1995
Neutralization of heparin activity by neutrophil lactoferrinH F Wu, R L Lundblad, F C Church
International Journal of Peptide and Protein Research|January 1, 1995
Designed polyanionic coiled-coil proteins: acceleration of heparin cofactor II inhibition of thrombinL G Melton, F C Church, B W Erickson
Arteriosclerosis, Thrombosis, and Vascular Biology|September 1, 1996
Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor IIR A Shirk, F C Church, W D Wagner
Leukemia Research|June 27, 2000
Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemiaJ E Bushman, D Palmieri, H C Whinna, et al.
Biochimica Et Biophysica Acta|October 16, 1991
The effects of heparin cofactor II-derived chemotaxins on neutrophil actin conformation and cyclic AMP levelsM Hoffman, K A Faulkner, M A Iannone, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Archives of Biochemistry and Biophysics|April 1, 1988
In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitorsC W Pratt, F C Church, S V Pizzo
Journal of Protein Chemistry|November 20, 1997
Assessment of the interaction between urokinase and reactive site mutants of protein C inhibitorT P Jackson, S T Cooper, F C Church
Archives of Biochemistry and Biophysics|April 1, 1986
Structure-function relationships in heparin cofactor II: chemical modification of arginine and tryptophan and demonstration of a two-domain structureF C Church, G B Villanueva, M J Griffith
Archives of Biochemistry and Biophysics|July 2, 1998
Contribution of basic residues of the D and H helices in heparin binding to protein C inhibitorL L Neese, C A Wolfe, F C Church
The Journal of Biological Chemistry|May 30, 1997
Arginine 200 of heparin cofactor II promotes intramolecular interactions of the acidic domain. Implication for thrombin inhibitionA V Ciaccia, D M Monroe, F C Church
Blood|January 15, 1995
Neutralization of heparin activity by neutrophil lactoferrinH F Wu, R L Lundblad, F C Church
International Journal of Peptide and Protein Research|January 1, 1995
Designed polyanionic coiled-coil proteins: acceleration of heparin cofactor II inhibition of thrombinL G Melton, F C Church, B W Erickson
Arteriosclerosis, Thrombosis, and Vascular Biology|September 1, 1996
Arterial smooth muscle cell heparan sulfate proteoglycans accelerate thrombin inhibition by heparin cofactor IIR A Shirk, F C Church, W D Wagner
Leukemia Research|June 27, 2000
Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemiaJ E Bushman, D Palmieri, H C Whinna, et al.
Biochimica Et Biophysica Acta|October 16, 1991
The effects of heparin cofactor II-derived chemotaxins on neutrophil actin conformation and cyclic AMP levelsM Hoffman, K A Faulkner, M A Iannone, et al.
Pageof 8